Clinical Trials Directory

Trials / Completed

CompletedNCT00360477

FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy

Prospective Randomized Trial of Floseal Tubeless Exit vs. Cope Loop Nephrostomy vs. Fascial Stitch Following Percutaneous Nephrolithotripsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
59 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The patient will be asked to participate in a research project designed to determine the best way to prevent bleeding and promote patient comfort after having kidney stones removed. Two standard methods for ending the surgery are being compared to a newer method. In one standard method, the patient will have a tube draining urine from the kidney after the procedure. This tube may also prevent bleeding from the kidney. In another standard method the patient will have a tube left internally that drains urine from the kidney to the bladder and a stitch will be used to close the incision and deeper tissues in the back. In the third potential option, a tube would be left internally to drain urine from the kidney to the patient's bladder and the surgical site would be filled with a clot promoting agent (FloSeal) which is a FDA approved agent specifically formulated to stop bleeding during surgical procedures.

Conditions

Interventions

TypeNameDescription
PROCEDUREFlosealBioglue that seals the kidney
PROCEDURECope LoopNephrostomy tube for fluid drainage from the kidney
PROCEDUREFascial StitchStitch that closes the kidney

Timeline

Start date
2004-06-01
Primary completion
2014-10-01
Completion
2015-01-01
First posted
2006-08-04
Last updated
2016-12-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00360477. Inclusion in this directory is not an endorsement.